Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $152 | Backorder | |
10 mg | $255 | Backorder | |
25 mg | $461 | Backorder | |
50 mg | $875 | Backorder | |
100 mg | $1,496 | Backorder | |
200 mg | $2,323 | Backorder |
Description | Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regula |
Alias | Ac-Arg-Aib-Arg-α(Me)Phe-NH2 |
Molecular Weight | 617.756 |
Formula | C28H47N11O5 |
Cas No. | 1006388-38-0 |
Relative Density. | 1.34 g/cm3 (Predicted) |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.